334 related articles for article (PubMed ID: 7745730)
1. Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains.
Mammano F; Kondo E; Sodroski J; Bukovsky A; Göttlinger HG
J Virol; 1995 Jun; 69(6):3824-30. PubMed ID: 7745730
[TBL] [Abstract][Full Text] [Related]
2. HIV-1 Matrix Trimerization-Impaired Mutants Are Rescued by Matrix Substitutions That Enhance Envelope Glycoprotein Incorporation.
Tedbury PR; Novikova M; Alfadhli A; Hikichi Y; Kagiampakis I; KewalRamani VN; Barklis E; Freed EO
J Virol; 2019 Dec; 94(1):. PubMed ID: 31619553
[TBL] [Abstract][Full Text] [Related]
3. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.
Freed EO; Martin MA
J Virol; 1996 Jan; 70(1):341-51. PubMed ID: 8523546
[TBL] [Abstract][Full Text] [Related]
4. Sequence Determinants in Gammaretroviral Env Cytoplasmic Tails Dictate Virus-Specific Pseudotyping Compatibility.
Song YE; Olinger GY; Janaka SK; Johnson MC
J Virol; 2019 Jun; 93(11):. PubMed ID: 30894464
[TBL] [Abstract][Full Text] [Related]
5. Trimer Enhancement Mutation Effects on HIV-1 Matrix Protein Binding Activities.
Alfadhli A; Mack A; Ritchie C; Cylinder I; Harper L; Tedbury PR; Freed EO; Barklis E
J Virol; 2016 Jun; 90(12):5657-5664. PubMed ID: 27030269
[TBL] [Abstract][Full Text] [Related]
6. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail.
Murakami T; Freed EO
J Virol; 2000 Apr; 74(8):3548-54. PubMed ID: 10729129
[TBL] [Abstract][Full Text] [Related]
7. Role of the Gag matrix domain in targeting human immunodeficiency virus type 1 assembly.
Ono A; Orenstein JM; Freed EO
J Virol; 2000 Mar; 74(6):2855-66. PubMed ID: 10684302
[TBL] [Abstract][Full Text] [Related]
8. Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific, single amino acid substitutions in the human immunodeficiency virus type 1 matrix.
Freed EO; Martin MA
J Virol; 1995 Mar; 69(3):1984-9. PubMed ID: 7853546
[TBL] [Abstract][Full Text] [Related]
9. Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein.
Dorfman T; Mammano F; Haseltine WA; Göttlinger HG
J Virol; 1994 Mar; 68(3):1689-96. PubMed ID: 8107229
[TBL] [Abstract][Full Text] [Related]
10. Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity.
Murakami T; Ablan S; Freed EO; Tanaka Y
J Virol; 2004 Jan; 78(2):1026-31. PubMed ID: 14694135
[TBL] [Abstract][Full Text] [Related]
11. HIV cell-to-cell transmission requires the production of infectious virus particles and does not proceed through env-mediated fusion pores.
Monel B; Beaumont E; Vendrame D; Schwartz O; Brand D; Mammano F
J Virol; 2012 Apr; 86(7):3924-33. PubMed ID: 22258237
[TBL] [Abstract][Full Text] [Related]
12. The role of matrix in HIV-1 envelope glycoprotein incorporation.
Tedbury PR; Freed EO
Trends Microbiol; 2014 Jul; 22(7):372-8. PubMed ID: 24933691
[TBL] [Abstract][Full Text] [Related]
13. Elucidating the mechanism by which compensatory mutations rescue an HIV-1 matrix mutant defective for gag membrane targeting and envelope glycoprotein incorporation.
Tedbury PR; Mercredi PY; Gaines CR; Summers MF; Freed EO
J Mol Biol; 2015 Mar; 427(6 Pt B):1413-1427. PubMed ID: 25659909
[TBL] [Abstract][Full Text] [Related]
14. The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells.
Lodge R; Göttlinger H; Gabuzda D; Cohen EA; Lemay G
J Virol; 1994 Aug; 68(8):4857-61. PubMed ID: 8035484
[TBL] [Abstract][Full Text] [Related]
15. Structural characterization of HIV-1 matrix mutants implicated in envelope incorporation.
Eastep GN; Ghanam RH; Green TJ; Saad JS
J Biol Chem; 2021; 296():100321. PubMed ID: 33485964
[TBL] [Abstract][Full Text] [Related]
16. Truncation of the human immunodeficiency virus type 1 envelope glycoprotein allows efficient pseudotyping of Moloney murine leukemia virus particles and gene transfer into CD4+ cells.
Mammano F; Salvatori F; Indraccolo S; De Rossi A; Chieco-Bianchi L; Göttlinger HG
J Virol; 1997 Apr; 71(4):3341-5. PubMed ID: 9060707
[TBL] [Abstract][Full Text] [Related]
17. Identification of domains in the simian immunodeficiency virus matrix protein essential for assembly and envelope glycoprotein incorporation.
González SA; Burny A; Affranchino JL
J Virol; 1996 Sep; 70(9):6384-9. PubMed ID: 8709267
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6(Gag) protein produces a mutant that fails to package its envelope protein.
Ott DE; Chertova EN; Busch LK; Coren LV; Gagliardi TD; Johnson DG
J Virol; 1999 Jan; 73(1):19-28. PubMed ID: 9847302
[TBL] [Abstract][Full Text] [Related]
19. A combination anti-HIV-1 gene therapy approach using a single transcription unit that expresses antisense, decoy, and sense RNAs, and trans-dominant negative mutant Gag and Env proteins.
Ding SF; Lombardi R; Nazari R; Joshi S
Front Biosci; 2002 Feb; 7():a15-28. PubMed ID: 11815282
[TBL] [Abstract][Full Text] [Related]
20. Cleavage of the murine leukemia virus transmembrane env protein by human immunodeficiency virus type 1 protease: transdominant inhibition by matrix mutations.
Kiernan RE; Freed EO
J Virol; 1998 Dec; 72(12):9621-7. PubMed ID: 9811695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
